| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 06/21/2000 | EP1009752A1 Novel molecules of the tango-77 related protein family and uses thereof |
| 06/21/2000 | EP1009444A2 Compositions and methods for treating arthritis utilizing gene therapy |
| 06/21/2000 | EP1009443A1 priA POLYPEPTIDES |
| 06/21/2000 | EP1009442A1 Improvements in or relating to regulation of t cell activation |
| 06/21/2000 | EP1009441A1 Method for the treatment of grafts |
| 06/21/2000 | EP1009438A1 Dried biologically or therapeutically active preparations |
| 06/21/2000 | EP1009437A1 Use of propyl gallate to increase bioavailability of orally administered pharmaceutical compounds |
| 06/21/2000 | EP1009435A1 Method for preventing hiv-1 infection of cd4?+ cells |
| 06/21/2000 | EP1009432A1 Composition and method to prevent graft rejection and other counter-adaptive t lymphocyte mediated immune responses |
| 06/21/2000 | EP1009431A1 Human tumor necrosis factor receptor-like 2 (tr2) antibodies |
| 06/21/2000 | EP1009427A1 USE OF FACTOR XIIIa INHIBITORS TO TREAT ATHEROSCLEROSIS |
| 06/21/2000 | EP1009426A1 Method for treating a subject suffering from conditions associated with an extracellular zinc sphingomyelinase |
| 06/21/2000 | EP1009425A1 Wound healing |
| 06/21/2000 | EP1009424A2 Regulation of muscle tissues by hedgehog-like polypeptides, and formulations and uses related thereto |
| 06/21/2000 | EP1009423A1 EPO PRIMARY RESPONSE GENE, EPRG3pt |
| 06/21/2000 | EP1009422A1 STRUCTURE OF THE ANKYRIN BINDING DOMAIN OF A ALPHA-Na,K-ATPase |
| 06/21/2000 | EP1009421A1 Methods and compositions for enhanced wound healing |
| 06/21/2000 | EP1009420A1 Conjugates useful in the treatment of prostate cancer |
| 06/21/2000 | EP1009419A2 Graminae pollen allergen mutants for specific immunotherapy, and production and use of the same |
| 06/21/2000 | EP1009418A1 Robinia pseudoacacia lectin and its uses |
| 06/21/2000 | EP1009417A1 Dietary supplements containing natural ingredients |
| 06/21/2000 | EP1009411A1 Method and composition for treating sleep apnea |
| 06/21/2000 | EP1009400A1 Combination therapy comprising atorvastatin and an antihypertensive agent |
| 06/21/2000 | EP1009395A1 Bak promotor expression system |
| 06/21/2000 | EP1009232A1 Methods for treating insulin resistance and identifying patients at risk for the disease |
| 06/21/2000 | EP0205564B2 Method for the production of erythropoietin |
| 06/21/2000 | DE19916224C1 Synthetic molecule for delivering active ingredient to cell, used e.g. to treat human immune deficiency virus infection, comprises the ingredient linked to VP2 or 3 peptide from polyoma virus |
| 06/21/2000 | DE19858463A1 Verwendung eines Fibrinklebers zur Regeneration des Lebergewebes Use of fibrin glue for the regeneration of liver tissue |
| 06/21/2000 | DE19858441A1 FV-Vektoren zur Expression von Fremdgenen in Säugern und deren Verwendung FV vectors for expression of foreign genes in mammals and the use thereof |
| 06/21/2000 | DE19856443A1 Stabilisiertes Antithrombin III-Präparat Stabilized antithrombin III preparation |
| 06/21/2000 | DE19851294C1 Ischämie/reperfusionsinduzierbare DNAs und Proteine Ischemia / reperfusionsinduzierbare DNAs and proteins |
| 06/21/2000 | CN1257545A Type II TGF-beta receptor/immunoglobulin constant region fusion proteins |
| 06/21/2000 | CN1257539A Short peptides which selectively modulate intracellular signalling |
| 06/21/2000 | CN1257538A Short peptides which selectively modulate the activity of serine/threonine kinases |
| 06/21/2000 | CN1257510A New BPC peptide salts with organo-protective activity, the process for their preparation and their use in therapy |
| 06/21/2000 | CN1257430A Use of hyaluronidase in the manufacture of an ophthalmic preparation for liquefying vitreous humor in the treatment of eye disorders |
| 06/21/2000 | CN1257423A Preparation of powder agglomerates |
| 06/21/2000 | CN1256951A Stomach health care enzyme |
| 06/21/2000 | CN1256950A Chongcaobaochun liquid and making method thereof |
| 06/21/2000 | CN1053700C Recombination of human macrophage colony stimulating factor by domestic silkworm gene engineering |
| 06/21/2000 | CN1053694C Process for brewing beer containing SOD |
| 06/21/2000 | CN1053693C Process for brewing beer containing SOD, hedgehogt polysaccharide and theaflavin |
| 06/21/2000 | CN1053586C Ointment for treating scald |
| 06/20/2000 | US6077987 Implanting in a patient isolated cells genetically engineered in vitro to express bioactive molecules selected from the group consisting of bone growth factors, cartilage growth factors, nerve growth factors, and general growth factors |
| 06/20/2000 | US6077950 Adjusting efficiency of animals antibody response by administering animal a polypeptide to activate antibody response |
| 06/20/2000 | US6077948 Mediators of chronic allograft rejection (AIF-1) and DNA encoding them |
| 06/20/2000 | US6077947 Nucleotide sequences coding a hybrid transmembrane protein; for the propagation mitosis in cells; for the treatment of autoimmune disease and infections; anticarcinogenic agents |
| 06/20/2000 | US6077939 Methods and kits for making polypeptides having a single covalently bound N-terminal water-soluble polymer |
| 06/20/2000 | US6077936 Multidrug resistance-associated polypeptide |
| 06/20/2000 | US6077935 Unglycosylated viral polypeptide; for the detection of viral antigens in human blood; for vaccine development |
| 06/20/2000 | US6077934 Contryphan peptides |
| 06/20/2000 | US6077856 Hemoregulatory compounds |
| 06/20/2000 | US6077834 Combining non-viral receptor ligand and cationic lipid ; adding polynucleotide to form molecular mixture; introducing molecular mixture to cell to enhance delivery of polynucleotide to cell |
| 06/20/2000 | US6077833 Oligonucleotide compositions and methods for the modulation of the expression of B7 protein |
| 06/20/2000 | US6077829 Comprising brain derived neurotrophic factor(bdnf), polyoxyethylene sorbitan monooleate as nonionic surfactant, and carrier; prevents denaturing and polymerization of bdnf; storage stability |
| 06/20/2000 | US6077827 Family of peptides known as xenoxins |
| 06/20/2000 | US6077826 Synthetic peptides comprising segments of naturally occuring channel proteins capable of forming multiple-peptide channel assemblies for transport of anions through epithilial cells |
| 06/20/2000 | US6077825 Useful in medical treatments where antithrombin agents are needed |
| 06/20/2000 | US6077823 Administering morphogen other than tgf(transforming growth factor)-.beta..sub.2 to tissue affected by immune cell mediated inflammatory or fibrogenic response, said morphogen comprising a dimeric protein |
| 06/20/2000 | US6077822 Drug salts |
| 06/20/2000 | US6077706 Helicobacter pylori proteins useful for vaccines and diagnostics |
| 06/20/2000 | US6077705 An expression vector for the treatment of the alpha antitrypsin mutation; for gene therapy |
| 06/20/2000 | US6077701 Ikkβ regulates transcription factors |
| 06/20/2000 | US6077697 Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes |
| 06/20/2000 | US6077693 Polynucleotide encoding a promonocyte associated protein |
| 06/20/2000 | US6077692 Amino acid sequence of polypeptide for use as wound healing agents, antiulcer agents, antidiabetic agents; treatment of inflammatory bowel disease, lung damage, gastrointestinal and oral injury, gut toxicity, skin grafts and disorders |
| 06/20/2000 | US6077687 Flea aminopeptidase nucleic acid molecules and uses thereof |
| 06/20/2000 | US6077686 Nucleotide and amino acid sequences of protein expressed in adult brain; mediates tyrosine kinases in the nervous system such as receptors for nerve growth factors; antitumor agents; treatment/diagnosis of nervous system disorders |
| 06/20/2000 | US6077685 Tumor suppressor merlin and antibodies thereof |
| 06/20/2000 | US6077680 Inhibiting kv1 potassium channel activity in a lymphocyte of an animal by administering polypeptide of specific amino acid sequence; for treatment of autoimmune disorders |
| 06/20/2000 | US6077679 Herpes virus proteinase and method of assaying |
| 06/20/2000 | US6077677 Amino acid sequence; bactericides; prophylactic agents; diagnosis; drug screening |
| 06/20/2000 | US6077675 Drug screening by contacting compound with recombinant cell which expresses a nucleic acid encoding the receptor and monitoring for binding or modulation of receptor; anticonvulsants; analgesics; cognition enhancers |
| 06/20/2000 | US6077672 Antisense modulation of TRADD expression |
| 06/20/2000 | US6077668 Highly sensitive multimeric nucleic acid probes |
| 06/20/2000 | US6077663 Composition for introducing nucleic acid complexes into higher eucaryotic cells |
| 06/20/2000 | US6077543 Atomizing solutions to produce drops; lung drug delivery |
| 06/20/2000 | US6077523 Process to manufacture implants containing bioactive peptides |
| 06/20/2000 | US6077519 Antitumor vaccine comprising t-cell epitopes recovered through acid elution from patient's viable resected tumor tissue and as adjuvant dendritic cells and/or cytokines |
| 06/20/2000 | US6077518 Cloning of mite allergens |
| 06/20/2000 | US6077517 House dust mite allergen, Der p VII, and uses thereof |
| 06/20/2000 | US6077511 Antigenic peptide derived from the G protein of RSV for type- and subtype-specific diagnosis of respiratory syncytial virus (RSV) infection |
| 06/20/2000 | US6077510 Borna disease viral sequences, diagnostics and therapeutics for nervous system diseases |
| 06/20/2000 | US6077509 Given amino acid sequences that are immunodominant in humans suffering from multiple sclerosis |
| 06/20/2000 | US6077507 Method of making a composition comprising a fibrin monomer |
| 06/20/2000 | US6077499 First conjugate of a tumor targeting moiety, a therapeutic agent, and first member of a binding pair; clearing agent; and second conjugate of the complementary binding member of the binding pair, and second therapeutic agent |
| 06/20/2000 | US6077447 Includes a platen having a surface configured for heat exchange with a container adhered to the platen by device of a vacuum and heat exchange allowing both cooling and heating to occur along the boundary between the container and the platen |
| 06/20/2000 | CA2210241C Pharmaceutical composition containing cyclosporin for treating a human with nervous insult |
| 06/20/2000 | CA2204263C Germicidal detergent-iodine compositions including polyvinyl pyrrolidone and compatible nonionic surfactant complexors |
| 06/20/2000 | CA2175337C Method and composition for treatment of patients having decompensated liver disease |
| 06/20/2000 | CA2144845C Germicidal detergent-iodine compositions having reduced detergent content |
| 06/20/2000 | CA2125284C Peroral administration form for peptidic medicaments, in particular insulin |
| 06/20/2000 | CA2122598C Treatment of protozoal infection with bacitracin |
| 06/20/2000 | CA2001303C Endothelin dna and use thereof |
| 06/20/2000 | CA1341032C Anticoagulant peptides |
| 06/20/2000 | CA1341029C Peptidase inhibitors |
| 06/18/2000 | CA2292481A1 Use of fibrin adhesive for tissue regeneration |
| 06/17/2000 | CA2292474A1 Process for dissolving albumin flakes in a liquid and arrangement for carrying out the process |
| 06/15/2000 | WO2000034780A2 METHODS AND COMPOSITIONS USEFUL FOR TARGETING ACTIVATED VITRONECTIN RECEPTOR αvβ¿3? |
| 06/15/2000 | WO2000034529A1 Complete genome sequence of a simian immunodeficiency virus from a red-capped mangabey |